Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, following positive Phase 1b interim data; development plan ...

Syracuse, N.Y. — Hundreds of thousands of people who use at-home catheters risk a troublesome – and occasionally ...

Reported updated results from 12 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led ...

To fast-track water infrastructure in underserved provinces, the Department of Environment and Natural Resources (DENR), ...

Understand the impact of AI coding on scientific workflows and how it can make computational tools more accessible to ...

Billions are being invested in Europe’s life sciences CapEx sector, supporting new biologics plants, sterile fill‑finish facilities, and advanced therapy suites. Engineering roles in pharma and ...

Incumbent Steve Andrews and challengers Stephanie Sheedy and Mike Spice will vie for two seats on the Suamico Village Board in the spring 2026 general election. Both seats are at-large, meaning the ...

PHILADELPHIA, PA / ACCESS Newswire / March 19, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, and digital engagement, and ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, ...

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.